and exons 7 -I 0 (Fuchs et al., 1994) , due to the presence of a related pseudogene (Braun et al., 1996) , but we could successfully amplify these exons. Genomic D N A was extracted from peripheral blood leukocytes and 100 ng was used as a template in the PCR. Direct sequencing of the amplified fragments was performed with either of the P C R primers. Only for exon 1 the products were cloned into a plasmid, pUC119, and sequenced. Two internal PstI sites, which gave 283 bp, 189 bp and 579 bp fragments u p o n cleavage of the product (1,051 bp) with the enzyme, were used for subcloning and sequencing. When a point mutation was found, other subclones from the same patient were examined for verification. With regard to exons 9 and 10, two internal primers were also used for direct sequencing. . This is a missense mutation at codon 302 (Glu-*Lys), which occurred de novo, because the mother is normal at this site (lane 2). (b) Exon 6 was PCR-amplified from the genomic DNA and directly sequenced with the upstream primer. It reads CTCTGGCCCACGTACGGT-GGTGTGCTCTACAAGCCCC in the control (lane 1), but the G (nucleotide number= 1971) is deleted (indicated by an arrow) in the patient (lane 3) and also in his younger brother (lane 4). Since the mother is heterozygous for the mutation, the sequence beyond this site is hardly readable (lane 2).
One of the patients (H.Y.) showed a gait disturbance at the onset of the disease at age 10 years, and spastic quadriplegia, blindness, deafness and adrenal failure became evident later. He was finally diagnosed as ALD from the level of very-long-chain fatty acids in erythrocyte membrane sphingomyelin (Tanaka et al., 1986) and by histologic examination of the rectal mucosa for cytoplasmic lamellar inclusions (Tanaka et al., 1987) . On analysis of the ALD gene of the patient, we found a missense mutation in exon 2 (Glu3~ G1290A) (Fig. la) , which was the only abnormality present in the 10 exons and their adjacent introns we sequenced. This is the first report on a mutation present in exon 2. The Glu a~ exists in the intraperoxisomal region between the fifth and the sixth membranespanning domains, and conserved in the mouse homologue of ALD protein , and in the human and rat PMP70 proteins (corresponding to Glu 28s) (Kamijo et al., 1992) . There have been four reports on a missense mutation in this intraperoxisomal region: G1182A (Gly266-,Arg) Fuchs et al., 1994) , G1215T (Gly277---~Trp) (Kok et al., 1995) , G1215A (Gly277--~Arg) (Krasemann et al., 1996) , and G1257A (Glu291~kys) (Cartier et al., 1993) . These mutations and the one we found, all causing drastic substitutions of amino acids, may impair stability of the ALD protein. It is of interest that the patient's mother is normal for this site (Fig. la) , indicating that the mutation arose de novo. Such a de novo mutation of the ALD gene was also reported by others (Fanen et al., 1994; Barcel6 et al., 1995; Krasemann et al., 1996) . The mother showed as high a level of tetracosanoic (C24:0) and hexacosanoic (C26:0) acids in erythrocyte membrane sphingomyelin as hemizygous patients (Tanaka et al., 1986) . The discrepancy between the DNA and lipid analyses can be explained by germinal (and/or somatic) mosaicism, or it may simply suggest that lipid analysis is sometimes misleading in the carrier detection of ALD.
The other patient (K.A.) noticed visual impairment at the age 5 years. He later developed spastic quadriplegia, blindness and deafness, but no signs of adrenal failure until his death. The examinations by computed tomography of the skull for demyelination (Tanaka et al., 1986) , by rectal biopsy for lamellar inclusion bodies (Tanaka et al., 1987) , and of very-long-chain fatty acid content in the erythrocyte membrane (Tanaka et al., 1986) led to his final diagnosis of ALD. On analysis of the ALD gene of the patient, we found a frameshift mutation in exon 6 (Gly s29-frameshift, 197 ldelG) (Fig. Ib) , which causes premature termination of translation at nucleotides 2048-2050 (TGA), resulting in the elimination of one of the two ATP-binding cassettes (corresponding to nucleotides 2235-2276). Twenty-seven ALD cases have been suggested to be caused by frameshift mutations (Kemp et al., 1994; Ligtenberg et al., 1995; Braun et al., 1995; Song et al., 1995; Fanen et al., 1994; Barcel6 et al., 1994; Fuchs et al., 1994; Kok et al., 1995; Krasemann et al., 1996) , more than a half of them being the same defect (1801delAG), but the mutation we found has never been reported. The patient's mother is heterozygous for this site and his younger brother (S.A.) has the same deletion (Fig. lb) . Though the younger brother showed a high level of very-long-chain fatty acids in erythrocyte membrane sphingolipids and had lamellar inclusions in the biopsy specimen of rectal mucosa (Tanaka et al., 1987) , he has not yet manifested any clinical symptoms since these examinations were held (about 10 years ago). This is an example of variability of ALD, suggesting additional environmental and/or genetic factors influencing the phenotype.
